HENDERSON MICHAEL THOMAS sold 47.4% of their position (80K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.95M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 5/9/2026ACC: 0001636282-26-000053
Director
Since Jun 2023
-80K
Net shares
Net seller
$5.95M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
80K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−2.40K
Price / share
$72.57
Trade value
$174.46K
% of position
1.4%
5/8/2026
168.61K→166.20K
Common Stock
Direct
Shares
−33.51K
Price / share
$73.72
Trade value
$2.47M
% of position
20.2%
5/8/2026
166.20K→132.69K
Common Stock
Direct
Shares
−24.81K
Price / share
$74.76
Trade value
$1.86M
% of position
18.7%
5/8/2026
132.69K→107.88K
Common Stock
Direct
Shares
−19.27K
Price / share
$75.35
Trade value
$1.45M
% of position
17.9%
5/8/2026
107.88K→88.61K
Total
Net shares
−80K
Net value
-$5.95M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/8/2026 | S · Sale | −2.40K | $72.57 | $174.46K | 1.4% | 168.61K | 166.20K |
| Common Stock Direct | 5/8/2026 | S · Sale | −33.51K | $73.72 | $2.47M | 20.2% | 166.20K | 132.69K |
| Common Stock Direct | 5/8/2026 | S · Sale | −24.81K | $74.76 | $1.86M | 18.7% | 132.69K | 107.88K |
| Common Stock Direct | 5/8/2026 | S · Sale | −19.27K | $75.35 | $1.45M | 17.9% | 107.88K | 88.61K |
| Total | −80K | -$5.95M | ||||||
Derivative Transactions0
No derivative transactions reported